Skip to content

OUR MISSION

As an at-home blood collection device company, YourBio Health eliminates barriers to blood collection by allowing a capillary blood sample to be collected from any physical location without the pain of a fingerstick or need for traditional phlebotomy. Backed by the latest science, data management technology, and certified central laboratories, we guarantee best-in-class test results.

OUR MISSION

YourBio Health eliminates barriers to blood collection by allowing a patient blood sample to be collected from any physical location without the pain of a fingerstick or need for traditional phlebotomy. Backed by the latest science, data management technology, and certified central laboratories, we guarantee best-in-class test results.

Five avatars standing together with tab coats and various attire

our history

TAP®, “Touch Activated Phlebotomy”, was invented in Flagship’s lab to decentralize blood-based testing, a sample can be collected anywhere and delivered to a lab more conveniently, with less pain. We invented a technology for self collecting capillary blood which easy to use and virtually painless.

Today, our device and service envelop is used in clinical trials and wellness applications globally.

A history of the YourBio Health Company

TAP II Blood Collection Device and Avatar standing to the right with Clouds

our product

Traditional methods of blood draw through venipuncture usually require a visit to a clinic, lab or healthcare professional; where fingersticks typically involve discomfort and anxiety for the patient.

Unlike many blood collection companies, YourBio Health allows patients to easily draw with less pain and from the comfort of home or any other location they choose with our TAP II device.

TAP II is placed on the upper arm and blood collection starts with a simple press of a button. The process typically takes 2-3 minutes. This innovation provides easier and more cost-effective access to high quality central lab testing and is a game-changer for consumers, the health care system, and patients.

  • TAP II is currently CE Marked and available in select European countries.
  • TAP II is available for investigational use only (IUO) in the US and is not yet FDA cleared.

our team

Harry Wilcox - Our Executive Chairman

Harry
Wilcox

Executive Chairman

Jerry Brightbill - Our Chief Operating Officer

Jerry Brightbill

Chief Operating Officer

Hutan Ashrafian - Our Chief Medical Officer

Hutan Ashrafian

Chief Medical Officer

Sara Gilbert Leonard - Our Chief Marketing Officer

Sara Gilbert Leonard

Chief Marketing Officer

Stephen Hahn - Our Medical Advisor

Stephen Hahn

Medical Advisor

Ros Barker - Our Commercial Director for the UK and EU

Ros Barker

Commercial Director, UK and EU

Vinny Barone - Our Director of Engineering

Vinny Barone

Director of Engineering

Douglas Woodbury - Our Director of Quality

Douglas Woodbury

Director of Quality

our board of directors

Noubar Afeyan

CEO,
Flagship Pioneering

Thomas J. Cahill, MD, PhD 

Founder and Managing Partner,
Newpath Partners LLC

Don Hardison

President, CEO and
Director of Biotheranostics, Inc.

Peter Hutt, JD 

Senior Counsel,
Covington & Burling, LLP

Robert Langer, ScD

(Co-founder)
Institute Professor, MIT

Harry Wilcox

General Partner,
Flagship Pioneering

Ara Darzi

Chairman, Preemptive Medicine and Health Security Initiative,
Flagship Pioneering